Beyondspring Inc BYSI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/21/21 EDT
11.65UNCH (UNCH)
Volume
3,171
Close
11.65quote price arrow down-0.03 (-0.26%)
Volume
132,598
52 week range
9.24 - 17.81

...

Loading . . .
  • Open11.77
  • Day High11.92
  • Day Low11.56
  • Prev Close11.65
  • 52 Week High17.81
  • 52 Week High Date11/16/20
  • 52 Week Low9.24
  • 52 Week Low Date04/21/21

Key Stats

  • Market Cap455.63M
  • Shares Out39.11M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.51
  • YTD % Change-4.51

KEY STATS

  • Open11.77
  • Day High11.92
  • Day Low11.56
  • Prev Close11.65
  • 52 Week High17.81
  • 52 Week High Date11/16/20
  • 52 Week Low9.24
  • 52 Week Low Date04/21/21
  • Market Cap455.63M
  • Shares Out39.11M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.51
  • YTD % Change-4.51

RATIOS/PROFITABILITY

  • EPS (TTM)-1.89
  • P/E (TTM)-6.16
  • Fwd P/E (NTM)-5.15
  • EBITDA (MRQ)-64.134M
  • ROE (MRQ)-102.81%
  • Revenue (MRQ)180,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-35,456.11%
  • Debt To Equity (MRQ)2.45%

EVENTS

  • Earnings Date09/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Beyondspring Inc

There is no recent news for this security.

Profile

MORE
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology cancer therapies. The Company’s lead product Plinabulin, is being studied in late-stage clinical trials as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). The Company's product, Plinabulin, is a marine-derived small-molecule with a range of biological activities. Plinabulin...
Huang Lan Ph.D.
Chairman
Richard Daly
Chief Operating Officer
Elizabeth Czerepak
Chief Financial Officer
Ramon Mohanlal M.D., Ph.D.
Executive Vice President
Address
28 Liberty St Fl 39
New York, NY
10005-1451
United States

Top Peers

SYMBOLLASTCHG%CHG
PLSE
Pulse Biosciences Inc
17.56+0.22+1.27%
BDTX
Black Diamond Therapeutics Inc
12.47-0.08-0.64%
AKUS
Akouos Inc
13.64+0.54+4.12%
VIRX
Viracta Therapeutics Inc
12.82+0.06+0.47%
VKTX
Viking Therapeutics Inc
6.22+0.08+1.30%